ClinicalTrials.Veeva

Menu

CBT+ for Depression

I

Iowa State University

Status

Completed

Conditions

Major Depressive Disorder

Treatments

Behavioral: ActiveCBT
Behavioral: CalmCBT

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06001346
1R61MH129407-01A1 (U.S. NIH Grant/Contract)
1R61MH129407

Details and patient eligibility

About

This study investigates the effects of a novel intervention approach, intentionally sequencing aerobic exercise immediately prior to therapy sessions (i.e., cognitive behavioral therapy [CBT]) to determine its effects on both specific and common factors underlying the antidepressant effect of CBT (i.e., mechanisms of CBT). To assess the utility of this treatment augmentation, investigators plan to conduct a randomized controlled trial involving 40 adults with Major Depressive Disorder who will watch a nature documentary while either resting quietly (termed 'CalmCBT') or exercising at a moderate intensity ('ActiveCBT') immediately prior to 8 weekly sessions of CBT. It is hypothesized that target CBT mechanisms of antidepressant action (i.e., self-reported working alliance and behavioral activation) will be more effectively engaged by ActiveCBT vs. CalmCBT.

Full description

Frontline treatments for major depressive disorder (MDD), including cognitive behavioral therapy (CBT), have limited effectiveness, with half of patients not responding to CBT and half relapsing within 2 years. Strategies that increase the potency of MDD treatments are needed. We are testing a novel treatment strategy using aerobic exercise to prime a subsequent CBT session ('ActiveCBT'). Exercise priming is hypothesized to lead to greater engagement of CBT mechanisms of action through both common and specific factors linked to depression outcomes; this CBT augmentation approach has yet to be empirically tested. The study will consist of an 8-week randomized controlled trial in 40 adults with MDD performing 30-minutes of moderate exercise or quiet rest (CalmCBT vs. ActiveCBT) prior to weekly CBT sessions. Using a time- and attention-matched control, all participants will view a standardized documentary series for these 30 pre-therapy minutes with the only difference between groups being exercise or calmly resting. This project will also employ machine learning and natural language processing via the Lyssn platform to objectively evaluate the language and words used during therapy. The overall goals are to: 1) demonstrate exercise priming effects on target CBT mechanisms, 2) link psychological and neuroplastic exercise priming to CBT mechanisms, and 3) explore the sensitivity of objective machine learning-based markers from Lyssn to ActiveCBT-induced therapy differences. This trial will establish the potential for a subsequent confirmatory efficacy trial to rigorously test the potential of exercise priming to enhance treatment. If this innovative, biologically-informed approach successfully 'primes' subsequent therapy, this could be used to augment other treatments and in other disorders, significantly improving mental health treatment.

Enrollment

40 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with DSM-5 MDD, confirmed via SCID.
  • Having current depressive symptoms of at least mild severity defined by HAM-D rating ≥8.
  • Being between age 18 and 65.
  • Either not engaging in any mental health treatment (e.g., medication, psychological, or behavioral) OR on a stable mental health treatment regimen and willing to maintain it for the length of the intervention.
  • Willing and safe to exercise based on the Physical Activity Readiness Questionnaire.
  • Being CBT-naïve (as defined by never undergoing structured CBT).

Exclusion criteria

  • currently pregnant, nursing, or planning to become pregnant,
  • severe obesity (BMI=40)
  • diagnosed with lifetime or current Psychosis, Mania, or Bipolar Disorder, via the SCID
  • diagnosed with current Substance Use Disorder, via the SCID
  • pose an imminent risk of self-harm or harm to others, assessed via the C-SSRS
  • exhibit behavioral disturbance (e.g., aggression, mild-moderate cognitive impairment) that would significantly interfere with study participation, assessed by clinical research personnel

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

ActiveCBT
Experimental group
Description:
Participants will complete a standardized 30-minute exercise session on a stationary bike prior to therapy. Participants will view one of 8 standardized 30-minute nature documentary videos while exercising.
Treatment:
Behavioral: ActiveCBT
CalmCBT
Active Comparator group
Description:
Participants will view one of 8 standardized 30-minute nature documentary videos while resting quietly prior to therapy.
Treatment:
Behavioral: CalmCBT

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jacob Meyer, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems